IC
NMRA icon

IEQ Capital’s Neumora Therapeutics NMRA Stock Holding History

IEQ Capital’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,173
Closed -$23.6K – 2020
2025
Q4 		$23.6K Sell
13,173
-4,284
-25% -$9.38K ﹤0.01% 1823
2025
Q3 		$31.8K Sell
17,457
-48,736
-74% -$78.8K ﹤0.01% 1816
2025
Q2 		$48.5K Buy
66,193
+39,680
+150% +$30.1K ﹤0.01% 1766
2025
Q1 		$26.5K Sell
26,513
-10,340
-28% -$17.7K ﹤0.01% 1582
2024
Q4 		$391K Sell
36,853
-38,000
-51% -$455K ﹤0.01% 930
2024
Q3 		$989K Sell
74,853
-8,000
-10% -$93.3K 0.01% 549
2024
Q2 		$814K Hold
82,853
– – 0.01% 526
2024
Q1 		$1.14M Buy
+82,853
New +$1.34M 0.02% 432

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

IEQ Capital's NMRA Position: Q1 2026 in Review

IEQ Capital sold out of Neumora Therapeutics (NMRA) in Q1 2026, closing a stake of 13,173 shares — an estimated $23.6K sold.

IEQ Capital first reported a position in NMRA in Q1 2024 and held it in 8 quarters. The position peaked at $1.14M in Q1 2024. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • IEQ Capital reported no remaining Neumora Therapeutics position as of Q1 2026 after selling out during the quarter.
  • IEQ Capital sold 13,173 Neumora Therapeutics shares in Q1 2026, an estimated $23.6K.
  • IEQ Capital first reported a position in Neumora Therapeutics in Q1 2024 and held it in 8 quarters.
  • IEQ Capital's Neumora Therapeutics position peaked at $1.14M in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.